BlackRock’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VAXX
SWM
XT
CGL
GT
FDCDDQ
RF
BlackRock's VAXX Position: Q2 2024 in Review
BlackRock sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 2,623,052 shares — an estimated $1.88M sold.
BlackRock first reported a position in VAXX in Q3 2022 and held it in 7 quarters. The position peaked at $5.98M in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.
- BlackRock reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
- BlackRock sold 2,623,052 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1.88M.
- BlackRock first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 7 quarters.
- BlackRock's Vaxxinity, Inc. Class A Common Stock position peaked at $5.98M in Q2 2023.
- 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.